• (18)F-FDG PET/CT revealed sporadic schwannomatosis involving the lumbar spinal canal and both lower limbs: a case report
• <em>LZTR1</em>- and <em>SMARCB1</em>-Related Schwannomatosis
• A 37-year-old woman with schwannomatosis, who has undergone 10 neurosurgical procedures: the first case in Poland with the SMARC1B gene mutation
• A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials
• A Curious Case of Common Peroneal Nerve Schwannoma
• A novel induced pluripotent stem cell model of Schwann cell differentiation reveals <em>NF2</em> - related gene regulatory networks of the extracellular matrix
• A novel induced pluripotent stem cell model of schwann cell differentiation reveals <em>NF2</em> -related gene regulatory networks of the extracellular matrix
• A Rare Case of Hepatic Schwannoma in the Setting of Schwannomatosis
• A rare case of multifocal craniospinal leptomeningeal melanocytoma: A case report and scoping review
• A rare case of multifocal schwannomatosis with multiple lesions of the median nerve
• A rare case of schwannomatosis with meningioma: a case report
• A Recurrent Schwannoma in the Left Distal Ulnar Nerve
• A resected case of schwannomatosis involving an extremely rare phrenic neurogenic plexiform schwannoma
• A systematic review of targeted therapy for vestibular schwannoma in patients with <em>NF2-</em>related schwannomatosis
• Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration
• An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis
• Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations
• Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis
• Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience
• Brainstem Ischemic Syndrome in NF2-Related Schwannomatosis
• Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
• Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma
• Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes
• Coffin-Siris Syndrome and SMARCB1 Mutation Presenting With Schwannomatosis: A Case Report and Literature Review
• Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis
• Consensus recommendations on counselling in Phelan-McDermid syndrome, with special attention to recurrence risk and to ring chromosome 22
• Correction to: Vestibular dysfunction in <em>NF2</em>-related schwannomatosis
• Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis
• Culture of attenuated <em>Salmonella</em> Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control
• Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
• Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial
• Familial schwannomatosis carrying LZTR1 variant p.R340X with brain tumor: A case report
• Features of course of pain syndrome in patients with schwannomatosis
• Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis
• Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions
• Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials
• Giant sciatic nerve schwannoma: a rare case report and literature review
• Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules
• High-frequency ultrasound imaging findings in the diagnosis of segmental schwannomatosis of the ulnar nerve: case report and literature review
• Histological and molecular characteristics of tumours of the peripheral nervous system
• Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis
• Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
• Improved sensitivity for detection of pathogenic variants in familial <em>NF2</em>-related schwannomatosis
• Improved sensitivity for detection of pathogenic variants in familial NF2-related schwannomatosis
• Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis
• Intracerebral schwannoma in a pediatric patient with schwannomatosis: A case report and literature review
• Low back pain with axillary mass in a perimenopausal woman: A case of schwannomatosis mimicking metastasis
• LZTR1- and SMARCB1-Related Schwannomatosis
• Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis
• Managing Multiple Schwannomatosis of Vagus and Hypoglossal Nerves: The Unanticipated Complications
• Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness
• Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis
• Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function
• MRI features of benign peripheral nerve sheath tumors: how do sporadic and syndromic tumors differ?
• Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution
• Multiple intracranial schwannomas of the vestibular and trigeminal nerves: Technical note
• Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis
• Neurofibromatosis Type 1
• Neurofibromatosis- and schwannomatosis- associated tumors: Approaches to genetic testing and counseling considerations
• Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations
• New classification and approaches to the treatment of schwannomatosis
• NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues
• NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study
• Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials
• Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
• Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis
• Phelan-McDermid Syndrome-<em>SHANK3</em> Related
• Phenotypic Expansion of Autosomal Dominant <em>LZTR1</em>-Related Disorders with Special Emphasis on Adult-Onset Features
• Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases
• Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1
• Radiogenomics in NF2-Associated Schwannomatosis (Neurofibromatosis Type II): Exploratory Data Analysis
• Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
• Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials
• Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study
• Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System
• Schwannomatosis manifesting as multiple schwannomas in a single intercostal nerve
• Schwannomatosis: a Realm Reborn: year one
• Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation
• Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis
• Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis
• Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis
• Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related Schwannomatosis
• Submandibular nodal schwannoma: where did it come from?
• Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas
• Tandem resection of multiple spinal schwannomas
• Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours
• The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
• The comparable tumour microenvironment in sporadic and <em>NF2</em>-related schwannomatosis vestibular schwannoma
• The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial
• The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis
• Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation
• Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas
• Undiagnosed RASopathies in infertile men
• Unilateral Multifocal Inner Ear and Internal Auditory Canal or Cerebellopontine Angle Cochleovestibular Schwannomas-Genetic Analysis and Management by Surgical Resection and Cochlear Implantation
• Use of a Suction-Monopolar Stimulator for Continuous Neurophysiology Monitoring During Endonasal Resection of a Cavernous Sinus Schwannoma: 2-Dimensional Operative Video
• Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients